Vivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development
Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery [...]
Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery [...]
Physical elder abuse draws more public attention, but financial exploitation [...]
Losing a family member to a sudden accident changes your [...]
Post-traumatic headaches are one of the most common symptoms following [...]
For the study, 564 U.S. Special Operations Forces personnel (mean [...]
Brown brings more than 20 years of experience in mitochondrial [...]
On March 12, 2026, the first implant of the ProStyle M® [...]
Company Appoints D. Keith Grossman to Board of Directors The [...]
CE Marking and ARCH clinical trial data position the Liverty [...]
Variational AI introduces Enki 4: an improved algorithm and architecture [...]